ofloxacin has been researched along with Paratyphoid Fever in 8 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Paratyphoid Fever: A prolonged febrile illness commonly caused by several Paratyphi serotypes of SALMONELLA ENTERICA. It is similar to TYPHOID FEVER but less severe.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present study, 33 adult patients with salmonella infections consisting of 13 typhoid fever, 9 paratyphoid fever, 8 enterocolitis, 2 carriers, 1 acute gastroenteritis have been treated with ofloxacin." | 3.68 | [Ofloxacin treatment of salmonella infections]. ( Altay, G; Arman, D; Unlü, S, 1993) |
| "Typhoid and paratyphoid (enteric fever) are febrile bacterial illnesses common in many low- and middle-income countries." | 2.82 | Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins. ( Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N, 2022) |
| "Ofloxacin was also effective in the treatment of enteric fever, in which eradication was achieved in all seven patients." | 2.66 | Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections. ( Sahaphong, S; Srimuang, S; Tanphaichitra, D, 1986) |
| "210 clinical isolates of typhoid salmonellae, cultivated from blood of patients with typhoid fever (108 strains of Salmonella typhi, 99 strains of Salmonella paratyphi A and three strains of Salmonella paratyphi B) as well as 266 random clinical isolates of Escherichia coli (n = 152), Klebsiella spp." | 1.27 | In vitro activity of ofloxacin against 210 clinical isolates of typhoid salmonellae. ( Hannan, A, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kuehn, R | 3 |
| Stoesser, N | 3 |
| Eyre, D | 3 |
| Darton, TC | 3 |
| Basnyat, B | 4 |
| Parry, CM | 3 |
| Thompson, CN | 1 |
| Karkey, A | 1 |
| Dongol, S | 1 |
| Arjyal, A | 1 |
| Wolbers, M | 1 |
| Darton, T | 1 |
| Farrar, JJ | 1 |
| Thwaites, GE | 1 |
| Dolecek, C | 1 |
| Baker, S | 1 |
| Truusalu, K | 1 |
| Kullisaar, T | 1 |
| Hütt, P | 1 |
| Mahlapuu, R | 1 |
| Aunapuu, M | 1 |
| Arend, A | 1 |
| Zilmer, M | 1 |
| Mikelsaar, RH | 1 |
| Mikelsaar, M | 1 |
| Randhawa, VS | 1 |
| Kumar, A | 1 |
| Saili, A | 1 |
| Datta, V | 1 |
| Agrawal, C | 1 |
| Mehta, G | 1 |
| Unlü, S | 1 |
| Arman, D | 1 |
| Altay, G | 1 |
| Sabbour, MS | 1 |
| Osman, LM | 1 |
| Hannan, A | 1 |
| Tanphaichitra, D | 1 |
| Sahaphong, S | 1 |
| Srimuang, S | 1 |
1 review available for ofloxacin and Paratyphoid Fever
| Article | Year |
|---|---|
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone | 2022 |
3 trials available for ofloxacin and Paratyphoid Fever
| Article | Year |
|---|---|
Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Drug Resistance, Multipl | 2017 |
Experience with ofloxacin in enteric fever.
Topics: Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Drug Administration Schedule; Fem | 1990 |
Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Female; Gonorrhea; Humans; Male; Middle Aged; Ofloxa | 1986 |
4 other studies available for ofloxacin and Paratyphoid Fever
| Article | Year |
|---|---|
Immunological, antioxidative, and morphological response in combined treatment of ofloxacin and Lactobacillus fermentum ME-3 probiotic in Salmonella Typhimurium murine model.
Topics: Animals; Anti-Bacterial Agents; Cytokines; Disease Models, Animal; Glutathione Peroxidase; Glutathio | 2010 |
Paratyphoid sepsis.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bottle Feeding; Breast Feeding; Cesarean Section; Female; Fo | 2007 |
[Ofloxacin treatment of salmonella infections].
Topics: Carrier State; Humans; Ofloxacin; Paratyphoid Fever; Salmonella Food Poisoning; Salmonella Infection | 1993 |
In vitro activity of ofloxacin against 210 clinical isolates of typhoid salmonellae.
Topics: Anti-Bacterial Agents; Humans; Ofloxacin; Oxazines; Paratyphoid Fever; Salmonella; Salmonella paraty | 1986 |